Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.38 |
| ▸ | KDM5A | P29375 | 2/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.32 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.32 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1798448 | 0.85 | PABPC1 (0.41) | TSHRALDH1A1PABPC1ENPP2KDM5A | |
| SCHEMBL30527294 | 0.77 | ALDH1A1 (0.57) | TSHRALDH1A1PABPC1KDM5ARXFP1 | |
| SCHEMBL8763290 | 0.77 | ALDH1A1 (0.57) | TSHRALDH1A1PABPC1KDM5ARXFP1 | |
| SCHEMBL9893708 | 0.76 | TSHR (0.36) | TSHRALDH1A1 | |
| SCHEMBL29469192 | 0.73 | POLB (0.44) | TSHRALDH1A1PABPC1ENPP2RECQL | |
| SCHEMBL3198768 | 0.73 | POLB (0.44) | TSHRALDH1A1PABPC1ENPP2RECQL | |
| SCHEMBL14822549 | 0.73 | ENPP2 (0.43) | ALDH1A1ENPP2RECQLSMN1; SMN2LIPG | |
| SCHEMBL1331721 | 0.71 | LMNA (0.55) | TSHRALDH1A1PABPC1KDM5ASMN1; SMN2 | |
| SCHEMBL6524293 | 0.71 | ENPP2 (0.41) | ALDH1A1ENPP2RECQLSMN1; SMN2LIPG | |
| SCHEMBL1939410 | 0.71 | GAA (0.50) | TSHRALDH1A1PABPC1KDM5ARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-211384996-U | Formamido phenyl boric acid preparation reaction kettle device | 武汉利昌医药科技有限公司 | 2020-09-01 | — | — | CN | claimed |
| CN-211177765-U | Drying device for producing and preparing formamido phenyl boric acid | 武汉利昌医药科技有限公司 | 2020-08-04 | — | — | CN | claimed |
| CN-117342907-A | Method for preparing phenol by hydroxylation reaction of boric acid derivative in air under no-alkali condition without light catalyst | 江西科技师范大学 | 2024-01-05 | — | — | CN | disclosed |
| CN-211384996-U | Formamido phenyl boric acid preparation reaction kettle device | 武汉利昌医药科技有限公司 | 2020-09-01 | — | — | CN | disclosed |
| CN-211177765-U | Drying device for producing and preparing formamido phenyl boric acid | 武汉利昌医药科技有限公司 | 2020-08-04 | — | — | CN | disclosed |
| US-20180125798-A1 | Compounds and Methods for Modulating Serotonin Receptors in the Periphery | NORTHEASTERN UNIVERSITY | 2018-05-10 | — | — | US | disclosed |
| US-7998412-B2 | Ophthalmic device comprising a holographic sensor | SMART HOLOGRAMS LIMITED (GB) | 2011-08-16 | — | — | US | disclosed |
| US-20090021697-A1 | Ophthalmic Device Comprising a Holographic Sensor | SMART HOLOGRAMS LIMITED (GB) | 2009-01-22 | — | — | US | disclosed |
| US-20030220516-A1 | Process for the preparation of substituted phenylboronic acids | CLARIANT GMBH | 2003-11-27 | — | — | US | disclosed |
| US-6576789-B1 | Process for the preparation of substituted phenylboronic acids | CLARIANT GMBH (DE) | 2003-06-10 | — | — | US | disclosed |
| US-5104894-A | Ellagic acid analogues | UNIVERSITY OF GUELPH (CA) | 1992-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180125798-A1 | Compounds and Methods for Modulating Serotonin Receptors in the Periphery | HTR5A, HTR3A, HTR1A | TSHR 364/4885ALDH1A1 3040/4885PABPC1 3056/4885 |
| US-20030220516-A1 | Process for the preparation of substituted phenylboronic acids | ME1, KCNH1, CA6 | TSHR 3363/4885ALDH1A1 383/4885PABPC1 1682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.